Is it safe to continue biologic agents during surgery in patients with inflammatory bowel disease?

[摘要] Patients with inflammatory bowel disease who are taking monoclonal antibodies against tumor necrosis factor alpha (TNF), interleukins 12 and 23, or integrin can continue taking them around the time of surgery, but small-molecule drugs such as tofacitinib should be withheld.

[学科分类] 卫生学